ZA984832B - Pharmaceutical form for the administration of paclitaxel process for the preparation of a ready-to-use paclitaxel composition and use of this composition - Google Patents
Pharmaceutical form for the administration of paclitaxel process for the preparation of a ready-to-use paclitaxel composition and use of this compositionInfo
- Publication number
- ZA984832B ZA984832B ZA984832A ZA984832A ZA984832B ZA 984832 B ZA984832 B ZA 984832B ZA 984832 A ZA984832 A ZA 984832A ZA 984832 A ZA984832 A ZA 984832A ZA 984832 B ZA984832 B ZA 984832B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- paclitaxel
- ready
- administration
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9700515A BE1011216A3 (fr) | 1997-06-13 | 1997-06-13 | Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA984832B true ZA984832B (en) | 1999-01-04 |
Family
ID=3890575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA984832A ZA984832B (en) | 1997-06-13 | 1998-06-04 | Pharmaceutical form for the administration of paclitaxel process for the preparation of a ready-to-use paclitaxel composition and use of this composition |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR012972A1 (xx) |
AU (1) | AU7632198A (xx) |
BE (1) | BE1011216A3 (xx) |
WO (1) | WO1998057630A1 (xx) |
ZA (1) | ZA984832B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6964946B1 (en) | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
ES2316489T3 (es) | 2000-12-05 | 2009-04-16 | Childrens Hospital Los Angeles | Composiciones farmaceuticas de fenretinida que tienen biodisponibilidad aumentada y metodos de uso de las mismas. |
EP1498143A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
US20050016926A1 (en) | 2003-07-24 | 2005-01-27 | Dabur Research Foundation | Stabilized formulation |
EP1648988A1 (en) * | 2003-07-24 | 2006-04-26 | Dabur Research Foundation | Process for the purification of non-ionic solvents for stabilized injectable pharmaceutical formulations |
CN1853728A (zh) * | 2005-04-19 | 2006-11-01 | 上海天博生物科技有限公司 | 一种改善药物或营养物口服吸收的方法、配方及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
FR2678833B1 (fr) * | 1991-07-08 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes. |
EP1384474A1 (en) * | 1992-11-27 | 2004-01-28 | Napro Biotherapeutics, Inc. | Injectable composition containing taxol |
AU5553894A (en) * | 1992-11-27 | 1994-06-22 | F.H. Faulding & Co. Limited | Injectable taxol composition |
FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
US5681846A (en) * | 1995-03-17 | 1997-10-28 | Board Of Regents, The University Of Texas System | Extended stability formulations for paclitaxel |
-
1997
- 1997-06-13 BE BE9700515A patent/BE1011216A3/fr not_active IP Right Cessation
-
1998
- 1998-06-02 AU AU76321/98A patent/AU7632198A/en not_active Abandoned
- 1998-06-02 WO PCT/BE1998/000078 patent/WO1998057630A1/fr active Application Filing
- 1998-06-04 ZA ZA984832A patent/ZA984832B/xx unknown
- 1998-06-11 AR ARP980102786A patent/AR012972A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO1998057630A1 (fr) | 1998-12-23 |
AU7632198A (en) | 1999-01-04 |
AR012972A1 (es) | 2000-11-22 |
BE1011216A3 (fr) | 1999-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL174082A0 (en) | Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use for the preparation of a pharmaceutical composition | |
IL117728A0 (en) | Pharmaceutical compositions for transdermal administration | |
HUP0100136A3 (en) | 11-or 17-substituted estratriols, process for their preparation, use of them and pharmaceutical compositions containing the same | |
IL115483A0 (en) | Urea derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP9601566A2 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
HUP9901243A3 (en) | Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
IL115097A0 (en) | Pharmaceutical compositions adapted for oral administration | |
HUP9900605A3 (en) | Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them | |
IL118369A0 (en) | Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL131415A (en) | Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them | |
IL107978A0 (en) | Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
IL191582A (en) | Process for preparing a pharmaceutical composition containing Ritonbir and use of Britonbir crystalline form ii for the preparation of a drug | |
HUP0002517A3 (en) | Derivatives of acyl-piperazinil-pyrimidins, preparation thereof, pharmaceutical compositions containing them and their use as medicaments | |
IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
IL114670A0 (en) | Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof | |
IL123927A (en) | Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them | |
IL125820A0 (en) | Therapeutic agent for diabetes and a pharmaceutical composition containing the same | |
GB2305606B (en) | Drug delivery composition for the nasal administration of ICAM-1 | |
IL115272A0 (en) | Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof | |
HUP0101256A3 (en) | Pharmaceutical composition having antitumor activity and process for the preparation thereof | |
ZA984832B (en) | Pharmaceutical form for the administration of paclitaxel process for the preparation of a ready-to-use paclitaxel composition and use of this composition | |
HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
HUP0003634A3 (en) | Use of thiazolidinedione and sulphonylurea derivatives for the preparation of pharmaceutical compositions treating diabetes | |
GB9518553D0 (en) | New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same |